Trojan-Horse Vaccine Unmasks ‘Immune-Cold’ Tumors
Learn how iVAC, a Trojan Horse-style intratumoural vaccine, forces immune-cold tumors to expose themselves and become visible targets for T cells, sparking a new era in immunotherapy.
Stay informed, stay connected—news for amigos everywhere.
Learn how iVAC, a Trojan Horse-style intratumoural vaccine, forces immune-cold tumors to expose themselves and become visible targets for T cells, sparking a new era in immunotherapy.
Researchers use drug-resistance mutations to guide new immunotherapy, offering hope for treatment-resistant tumors.
Chinese scientists reveal how breast cancer cells hijack arginine to reprogram immune cells and fuel tumor growth, opening doors to novel therapies.
U.S. researchers have developed an AI tool that uses simple blood tests to predict if cancer patients will respond to immunotherapy, marking a new era in personalized cancer treatment. 🚀